Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%

Healthcare

Page 64
  1. Feb 09, 2026 · 07:00 · ZYUS

    ZYUS Life Sciences Announces Filing of Amended and Restated LIFE Offering Document

    ZYUS Life Sciences Announces Filing of Amended and Restated LIFE Offering Document

    01
  2. Feb 09, 2026 · 07:00 · NGEN

    NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company's Growth and Execution of Its Mission in Spinal Cord Injury

    NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company's Growth and Execution of Its Mission in Spinal Cord Injury

    02
  3. Feb 09, 2026 · 03:01 · PREV

    PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents

    PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents

    03
  4. Feb 06, 2026 · 17:39 · MSCL

    Satellos Bioscience prices $50-million (U.S.) offering

    Satellos Bioscience prices $50-million (U.S.) offering

    04
  5. Feb 06, 2026 · 10:31 · VIVI

    Tempramed rolls out products to pharmacies in Israel

    Tempramed rolls out products to pharmacies in Israel

    05
  6. Feb 06, 2026 · 03:01 · VIVI

    TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

    TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

    06
  7. Feb 05, 2026 · 18:29 · PRN

    Profound sees Polish hospital complete 500th procedure

    Profound sees Polish hospital complete 500th procedure

    07
  8. Feb 05, 2026 · 18:00 · SKNY

    LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories

    LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories

    08
  9. Feb 05, 2026 · 17:16 · NGMD

    NuGen Medical Devices Inc. Provides Update on Health Canada License

    NuGen Medical Devices Inc. Provides Update on Health Canada License

    09
  10. Feb 05, 2026 · 16:53 · MYTC

    James Anderson Provides Update on Holdings of MyndTec Inc.

    James Anderson Provides Update on Holdings of MyndTec Inc.

    10
  11. Feb 05, 2026 · 16:30 · HBP

    Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

    Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

    11
  12. Feb 05, 2026 · 16:20 · MSCL

    Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq

    Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq

    12
  13. Feb 05, 2026 · 14:41 · BNXT

    Bionxt signs LOI for rights to drug chaperone technology

    Bionxt signs LOI for rights to drug chaperone technology

    13
  14. Feb 05, 2026 · 08:00 · PRN

    PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve(TM) Procedures, Expanding Access to Incision-Free Care for Women's Health

    PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve(TM) Procedures, Expanding Access to Incision-Free Care for Women's Health

    14
← Newer Older →